Area of research
Cardiology and Cardiovascular Medicine · Surgery
Research interest
Research interests include Acute Myocardial Infarction Research, Heart Failure Treatment and Management, Coronary Interventions and Diagnostics, and Cardiac Imaging and Diagnostics.
STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment–Elevation Myocardial Infarction: A Randomized, Open-Label Trial
Effect of Vericiguat on Left Ventricular Structure and Function in Patients with Heart Failure with Reduced Ejection Fraction: The VICTORIA Echocardiographic Substudy
Age, Sex, and Outcomes in Heart Failure With Reduced EF
Ejection Fraction, Biomarkers, and Outcomes and Impact of Vericiguat on Outcomes Across EF in VICTORIA
Sequential Evaluation of NT-proBNP in Heart Failure
Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the <scp>VICTORIA</scp> trial
Participation in a Heart Failure Clinical Trial
N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes
Association Between Glycated Haemoglobin Levels and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease: A Secondary Analysis of the TECOS Randomized Clinical Trial
Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) Trial
Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study
Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial
Association between bleeding and mortality among women and men with high-risk acute coronary syndromes: Insights from the Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial